BreakSight’s vision is to advance precision medicine by uncovering precise maps of DNA damage. Our technology identifies site-specific DNA breakage across the genome from DNA-damaging compounds. Our innovative and comprehensive platform enables discovery of novel DNA biomarkers of drug response by unraveling mechanisms of genomic instability caused by targeted therapeutics.
City of Hope, a world-renowned, National Cancer Institute-designated comprehensive cancer center, has one of the largest geographic footprints in cancer research and treatment, providing cancer patients with timely access to exceptional care, clinical trials and leading-edge innovation.
Inotiv provides a fully integrated drug discovery solution customized to your company’s project goals. We provide pharmacological, toxicological, and in vitro/in vivo assessment across multiple therapeutic areas and species to ensure the right studies are performed at the right time.